Calmare Therapeutics (CTTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 07-2007 | 07-2006 | 07-2005 | 07-2004 | 07-2003 | |
| Sales | 4,167 | 5,188 | 14,174 | 8,022 | 3,320 |
| Cost of Goods | 5,598 | 4,356 | 5,143 | 3,368 | 3,418 |
| Gross Profit | -1,431 | 832 | 9,032 | 4,654 | -98 |
| Operating Expenses | 7,311 | 3,612 | 3,462 | 2,028 | 1,311 |
| Operating Income | -8,144 | -2,424 | 5,712 | 2,994 | -991 |
| Other Income | -750 | 0 | 0 | -40 | -944 |
| Pre-tax Income | -8,894 | -2,424 | 5,712 | 2,955 | -1,935 |
| Income Tax | N/A | -47 | 10 | N/A | N/A |
| Net Income Continuous | -8,894 | -2,377 | 5,702 | 2,955 | -1,935 |
| Net Income | $-8,894 | $-2,377 | $5,702 | $2,955 | $-1,935 |
| EPS Basic Total Ops | -1.11 | -0.31 | 0.84 | 0.47 | -0.31 |
| EPS Basic Continuous Ops | -1.11 | -0.31 | 0.84 | 0.47 | -0.31 |
| EPS Diluted Total Ops | -1.11 | -0.31 | 0.78 | 0.46 | -0.31 |
| EPS Diluted Continuous Ops | -1.11 | -0.31 | 0.78 | 0.46 | -0.31 |
| EBITDA(a) | $-8,052 | $-2,378 | $5,745 | $3,053 | $-804 |